Head-to-Head: which seizure drug works best for kids?
NCT ID NCT07163585
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study compared two oral seizure medications, brivaracetam and levetiracetam, as first treatments in 102 children aged 1 month to 14 years with newly diagnosed epilepsy. Researchers looked at how well each drug stopped seizures and what side effects occurred. The goal is to help doctors choose the safest and most effective option for young patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
brivaracetam and levetiracetam (anti-seizure medications)
What this could lead to
If brivaracetam works as well or better with fewer side effects, it could become a preferred first-choice treatment for children with newly diagnosed epilepsy.
What could go wrong
This is a small, completed trial with 102 children, so results may not apply to all kids. Both drugs are already approved, so the main question is which is better tolerated, not a breakthrough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital and Institute of Child Health
Multan, Punjab Province, 66000, Pakistan